Singer group also found that the number and Foxp3 expression, activation state, suppressive phenotype, and proliferative capacity of CD4+CD25+Foxp3+Tregs in lung enhanced in mice treated by DNA methyltransferase inhibitor indicated that epigenetic pathways are very likely to be novel targets for the treatment of ARDS.75 This evidence concerns the gene CD4 and acute respiratory distress syndrome.